공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 측방유동 어세이 시장 예측(-2027년) : 제품, 용도, 기술, 최종 사용자별

Global Lateral Flow Assays Market by Product (Kits & Reagents, Instruments), Application (Clinical Testing, Veterinary, Food Safety), Technique (Sandwich, Multiplex), End User (Hospital, Diagnostic Labs) - Global Forecast to 2027

리서치사 SPER Market Research Pvt. Ltd.
발행일 2021년 08월 상품 코드 1023345
페이지 정보 영문 285 Pages
가격
US $ 3,400 ₩ 4,057,000 PDF (Single User License)
US $ 4,700 ₩ 5,608,000 PDF (Group License)
US $ 6,400 ₩ 7,637,000 PDF (Company License)


세계의 측방유동 어세이 시장 예측(-2027년) : 제품, 용도, 기술, 최종 사용자별 Global Lateral Flow Assays Market by Product (Kits & Reagents, Instruments), Application (Clinical Testing, Veterinary, Food Safety), Technique (Sandwich, Multiplex), End User (Hospital, Diagnostic Labs) - Global Forecast to 2027
발행일 : 2021년 08월 페이지 정보 : 영문 285 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 측방유동 어세이 시장은 2027년까지 140억 달러에 달해 2020년 9%의 CAGR 성장이 예측됩니다. 이 성장의 주요 요인은 감염 확산, 노인 인구 증가, POC 검사 및 가정용 측방유동 어세이 장치의 수요 증가입니다.

세계의 측방유동 어세이(Lateral Flow Assays) 시장을 조사 분석했으며, 시장 개요, 부문별 시장 분석, 경쟁 상황, 주요 기업 등 체계적인 정보를 제공합니다.

목차

제1장 서론

제2장 조사 방법

제3장 개요

제4장 시장 개요

  • 서론
  • 시장 역학
    • 촉진 요인
    • 억제 요인
    • 기회
    • 과제
  • 측방유동 어세이 시장 COVID-19의 영향

제5장 산업 고찰

  • 서론
  • 업계 동향

제6장 세계의 측방유동 어세이 시장 : 제품별

  • 키트 시약
  • 측면 흐름 리더

제7장 세계의 측방유동 어세이 시장 : 기술별

  • 샌드위치법
  • 경쟁법
  • 멀티 플렉스 검출법

제8장 세계의 측방유동 어세이 시장 : 샘플별

  • 혈액 샘플
  • 소변 샘플
  • 타액 샘플
  • 기타 샘플

제9장 세계의 측방유동 어세이 시장 : 용도별

  • 임상시험
  • 수의학용 진단
  • 식품 안전·환경 시험
  • 의약품 개발·품질 시험

제10장 세계의 측방유동 어세이 시장 : 최종 사용자별

  • 병원 클리닉
  • 진단 연구소
  • 재택 의료
  • 제약·바이오 기업
  • 최종 사용자

제11장 세계의 측방유동 어세이 시장 : 지역별

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 영국
    • 프랑스
    • 이탈리아
    • 스페인
    • 기타 유럽
  • 아시아태평양 지역
    • 중국
    • 일본
    • 인도
    • 기타 아시아태평양 지역
  • 기타 지역
    • 라틴아메리카
    • 중동·아프리카

제12장 경쟁 상황

  • 서론
  • 시장 점유율 분석 : 주요 기업별
  • 경쟁 상황 및 동향

제13장 기업 프로필

  • Abbott Laboratories(US)
  • F. Hoffman-La Roche Ltd.(Switzerland)
  • Danaher Corporation(US)
  • Siemens AG(Germany)
  • Becton, Dickinson and Company(US)
  • bioMerieux SA(France)
  • Bio-Rad Laboratories(US)
  • Thermo Fisher Scientific, Inc.(US)
  • PerkinElmer Inc.(US)
  • Hologic Inc.(US)
  • Quidel Corporation(US)
  • Merck KGaA(Germany)
  • Abcam plc(UK)
  • Surmodics IVD(US)
  • Chembio Diagnostic Systems, Inc.(US)
  • OraSure Technologies(US)
  • DCN Diagnostics(US)
  • Polysciences, Inc.(US)
  • Abingdon Health(UK)
  • BioPorto Diagnostics A/S(Denmark)
  • Microcoat Biotechnologie GmbH(Germany)
  • Scienion AG(Germany)
  • Senova GmbH(Germany)
  • Access Bio, Inc.(US)

제14장 부록

NJH 21.09.10

The global lateral flow assays market is expected to grow at a CAGR of ~9% from 2020 to reach ~14 billion by 2027. The growth is primarily attributed to prevalence of infectious diseases, growing geriatric population, increasing demand for POC testing and home-based lateral flow assay devices. However, lower accuracy and high margin of error associated with lateral flow assays is expected to hinder the growth of the market.

By Product: The lateral flow readers segment to grow at highest CAGR

The lateral flow readers provide the quantitative analysis of lateral flow strips. The lateral flow readers are expected to grow at the highest CAGR during the forecast period. The growth can be mainly attributed to high sensitivity and ability to quantify and accurately capture and transmit data.

By Technique: Sandwich assays accounted for the largest market share in 2020

Sandwich assays segment accounted for the largest market share of the lateral flow assay market, by technique in 2020. The large market share is mainly attributed to higher sensitivity, specificity for larger analyte and wide use of these assays.

By Sample Type: Other samples segment expected to register highest growth

Based on sample type, other samples segment is expected to grow at the highest CAGR in the forecast period. The growth is mainly ascribed by increasing R&D investments and escalating demand for precise disease testing.

By Application: Clinical testing expected to hold largest share in the lateral flow assays market

By application, lateral flow assays market is segmented into clinical testing, veterinary diagnostics, food safety & environment testing and drug development & quality testing. Clinical testing accounted for largest market share in the lateral flow assays market by application in 2020. This segment is further classified into pregnancy & fertility testing, infectious disease testing, cardiac marker testing, cholesterol testing/lipid profiles, drugs-of-abuse testing and other tests. The large share of this segment can be attributed to faster results for qualitative and quantitative analysis in POC testing.

By End User: Hospitals & clinics to dominate the lateral flow assays market

Hospitals & clinics segment accounted for largest share of the lateral flow segment market, by end user in 2020. The large share is mainly attributed to growing adoption of lateral flow assays, advantages over conventional testing and increased demand due to pandemic.

By Region: North America expected to dominate the regional market

North America is expected to dominate the lateral flow assays market by region. The large share is primarily attributed to prevalence of infectious diseases such as tuberculosis, Lyme disease, HIV/AIDS, increasing disposable income and rising geriatric population in the North America region. The pandemic has further boosted the market by increased investments in R&D. APAC is expected to register highest CAGR. The growth can be attributed to prevalence of chronic diseases, government initiatives and increasing healthcare expenditure in these countries.

Competitive Scenario

  • Abbott Laboratories (US)
  • F. Hoffman-La Roche Ltd. (Switzerland)
  • Danaher Corporation (US)
  • Siemens AG (Germany)
  • Becton, Dickinson and Company (US)
  • bioMerieux SA (France)
  • Bio-Rad Laboratories (US)
  • Thermo Fisher Scientific, Inc. (US)
  • PerkinElmer Inc. (US)
  • Hologic Inc. (US)
  • Quidel Corporation (US)
  • Merck KGaA (Germany)
  • Abcam plc (UK)
  • Surmodics IVD (US)
  • Chembio Diagnostic Systems, Inc. (US)
  • OraSure Technologies (US)
  • DCN Diagnostics (US)
  • Polysciences, Inc. (US)
  • Abingdon Health (UK)
  • BioPorto Diagnostics A/S (Denmark)
  • Microcoat Biotechnologie GmbH (Germany)
  • Scienion AG (Germany)
  • Senova GmbH (Germany)
  • and Access Bio, Inc. (US)

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Dynamics
    • 4.2.1. Drivers
    • 4.2.2. Restraints
    • 4.2.3. Opportunities
    • 4.2.4. Challenges
  • 4.3. COVID-19 Impact of the Lateral Flow Assay Market

5. Industry Insights

  • 5.1. Introduction
  • 5.2. Industry Trends

6. Global Lateral Flow Assay Market, By Product, 2019-2027 (USD Million)

  • 6.1. Kits & reagents
  • 6.2. Lateral flow readers

7. Global Lateral Flow Assay Market, By Technique, 2019-2027 (USD Million)

  • 7.1. Sandwich Assays
  • 7.2. Competitive Assays
  • 7.3. Multiplex Detection Assays

8. Global Lateral Flow Assay Market, By Sample, 2019-2027 (USD Million)

  • 8.1. Blood Samples
  • 8.2. Urine Samples
  • 8.3. Saliva Samples
  • 8.4. Other Samples

9. Global Lateral Flow Assay Market, By Application, 2019-2027 (USD Million)

  • 9.1. Clinical Testing
  • 9.2. Veterinary Diagnostics
  • 9.3. Food safety & Environment Testing
  • 9.4. Drug Development & Quality Testing

10. Global Lateral Flow Assay Market, By End User, 2019-2027 (USD Million)

  • 10.1. Hospitals & Clinics
  • 10.2. Diagnostics Laboratories
  • 10.3. Home Care Settings
  • 10.4. Pharmaceutical & Biotechnology Companies
  • 10.5. Other End Users

11. Global Lateral Flow Assay Market, By Geography, 2019-2027 (USD Million)

  • 11.1. North America
    • 11.1.1. US
    • 11.1.2. Canada
  • 11.2. Europe
    • 11.2.1. Germany
    • 11.2.2. UK
    • 11.2.3. France
    • 11.2.4. Italy
    • 11.2.5. Spain
    • 11.2.6. Rest of Europe
  • 11.3. Asia-Pacific
    • 11.3.1. China
    • 11.3.2. Japan
    • 11.3.3. India
    • 11.3.4. Rest of Asia-Pacific
  • 11.4. Rest of the World
    • 11.4.1. Latin America
    • 11.4.2. Middle East & Africa

12. Competitive Landscape

  • 12.1. Introduction
  • 12.2. Market Share Analysis, By Key Players (2020)
  • 12.3. Competitive Situation and Trends
    • 12.3.1. Product Launches
    • 12.3.2. Partnerships, Collaborations and Agreements
    • 12.3.3. Acquisitions
    • 12.3.4. Expansions
    • 12.3.5. Other Developments

13. Company Profiles

  • 13.1. Abbott Laboratories (US)
  • 13.2. F. Hoffman-La Roche Ltd. (Switzerland)
  • 13.3. Danaher Corporation (US)
  • 13.4. Siemens AG (Germany)
  • 13.5. Becton, Dickinson and Company (US)
  • 13.6. bioMerieux SA (France)
  • 13.7. Bio-Rad Laboratories (US)
  • 13.8. Thermo Fisher Scientific, Inc. (US)
  • 13.9. PerkinElmer Inc. (US)
  • 13.10. Hologic Inc. (US)
  • 13.11. Quidel Corporation (US)
  • 13.12. Merck KGaA (Germany)
  • 13.13. Abcam plc (UK)
  • 13.14. Surmodics IVD (US)
  • 13.15. Chembio Diagnostic Systems, Inc. (US)
  • 13.16. OraSure Technologies (US)
  • 13.17. DCN Diagnostics (US)
  • 13.18. Polysciences, Inc. (US)
  • 13.19. Abingdon Health (UK)
  • 13.20. BioPorto Diagnostics A/S (Denmark)
  • 13.21. Microcoat Biotechnologie GmbH (Germany)
  • 13.22. Scienion AG (Germany)
  • 13.23. Senova GmbH (Germany)
  • 13.24. Access Bio, Inc. (US)

14. Appendix

Back to Top
전화 문의
F A Q